Predictive model to estimate the chances of successful sperm retrieval by testicular sperm aspiration in patients with nonobstructive azoospermia
Testicular sperm aspiration is a less invasive alternative to microsurgical testicular sperm retrieval in nonobstructive azoospermia patients with serum follicle stimulating hormone <8.5 IU/L and average testis size >7.75 mL.
Ahmad Majzoub, M.D., Mohamed Arafa, M.D., Kareim Khalafalla, M.D., Sami AlSaid, M.D., Hasan Burjaq, Ph.D., Moza Albader, Ph.D., Thoraya Al-Marzooqi, M.D., Sandro C. Esteves, M.D., Haitham Elbardisi, M.D.
To explore predictors of successful sperm retrieval (SR) and to identify potentially suitable candidates for testicular sperm aspiration (TESA), a more straightforward, less traumatic, and less costly procedure than open surgical SR methods.
Retrospective chart review.
Academic tertiary medical center.
A total of 297 patients with nonobstructive azoospermia.
All patients underwent full clinical evaluation before undergoing a staged SR procedure, starting with TESA and proceeding to microsurgical testicular sperm extraction (microTESE). Predictors of positive SR with TESA were selected using the least absolute shrinkage and selection operator (LASSO) regression analysis using k-fold cross-validation. The obtained regression coefficients were used to create a predictive model, and a receiver operating characteristic (ROC) curve was obtained to express its predictive ability. Cut-off values for each significant predictor were also identified using ROC analysis.
Main outcome measure(s)
Development of a prediction model for positive SR with TESA.
Overall, a positive SR was observed in 23.6% of patients undergoing TESA. Average testis size (P= .017) and serum follicle-stimulating hormone (FSH) level (P< .001) were the significant predictors of positive SR identified by LASSO regression analysis. The predictive model had an AUC of 0.742 with a sensitivity of 73.9% and specificity of 69.9%. Patients presenting with an average testis size >7.75 mL and serum FSH level <8.5 IU/L had a TESA-positive SR of 43%.
TESA may be a suitable alternative to microTESE in selected nonobstructive azoospermia patients presenting with an average testis size >7.75 mL and serum FSH level <8.5 IU/L.
Editorial Office, American Society for Reproductive Medicine
Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activites described below. To learn more about how these trackers help us